Evidence map›Paper›PMID 24711827›Full record

ArticleIranian journal of pharmaceutical research : IJPR2014

Synthesis of N-arylmethyl Substituted Indole Derivatives as New Antiplatelet Aggregation Agents.

Masoud Faghih Akhlaghi, Salimeh Amidi, Marjan Esfahanizadeh, Marjan Daeihamed, Farzad Kobarfard

Open access · greenAbstract read
In one paragraph

Article in Iranian journal of pharmaceutical research : IJPR, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Masoud Faghih AkhlaghiDepartment of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran, Vali Asr Ave, Niayesh Junction, Tehran, Iran.
Salimeh AmidiDepartment of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran, Vali Asr Ave, Niayesh Junction, Tehran, Iran.
Marjan EsfahanizadehPhytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Iran.
Marjan DaeihamedDepartment of Pharmaceutics, School of Paharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Farzad KobarfardDepartment of Medicinal Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Iran, Vali Asr Ave, Niayesh Junction, Tehran, Iran. ; Phytochemistry Research Center, Shahid Beheshti University of Medical Sciences, Iran.
Shahid Beheshti University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A number of N-arylmethyl substituted indole derivatives have been synthesized and their effectiveness against ADP and arachidonic acid induced platelet aggregation in human plasma was determined. The desired compounds were synthesized by reacting the appropriate aniline derivative with isatin (or substituted isatin) to form the corresponding imine structures. The so formed compound was then activated using sodium hydride and reacted with the proper substituted benzyl halides. Among the tested compounds, derivatives 4a, 4c, 4d, 4f-i and 4k were the most potent compounds with satisfactory IC50 values (under 38.5 μM) for inhibition of platelet aggregation induced by arachidonic acid. All indole derivatives without substitution on position 1 of the indole ring, exhibited either weaker activities or were not active at all.

Indexed as

1-(substituted benzyl)-3-(phenylimino)indolin-2-oneAntiplateletN-arylmethyl indolePlatelet aggregation

Identifiers

PMID24711827
PMCPMC3977051
OpenAlexW1933858227

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.